Four weeks is not a month
The payment block offers a pay-monthly option and immediately defines it as billed every four weeks. Over a year that is thirteen charges rather than twelve, which adds close to a month's worth of cost to any annual comparison drawn against a seller who genuinely bills monthly.
The alternative on the same block is to pay for the whole twelve-week treatment at once, with the total printed against a struck-through anchor. That figure is a treatment total and we have stored it as one, not as a rate.
Two prices on one screen
The product hero advertises a starting price per four weeks. The payment block, further down the same page, gives a higher figure per four weeks for what reads as the same plan. Its own semaglutide-against-tirzepatide comparison block then repeats the higher figure.
Both are recorded here, each with the block it came from named in the qualifier. There is nothing on the page that resolves which one a buyer is actually charged.
The dose schedule, and the locale redirect
One thing this page does better than most: it prints the dose schedule week by week across three tiers, so a reader can see what strength arrives in which month rather than being told a plan is personalised.
The bare domain does not serve the US catalogue. It redirects to a locale path, which means the address a reader types and the address that answers are different, and any check made against the bare domain describes something other than what a US buyer sees. Its HIPAA notice names its own operating company and a pharmacy company.
FancyMeds's published pricing
| Medication | Price | Verified |
|---|---|---|
| Tirzepatide (compounded) | $299⛔ $299 billed every FOUR WEEKS, not per month — thirteen payments a year, $3,887, against $3,588 for twelve monthly payments of the same figure | September 2026source |
| Tirzepatide (compounded) | $199the same page's hero reads "Starting at $249 $199 / 4 weeks" while its payment block reads $299 billed every four weeks; both are published, and this is the lower of the two | September 2026source |
| Tirzepatide (compounded) | $799a one-time payment for the whole twelve-week treatment, published against a struck-through $1,149 | September 2026source |
| Semaglutide (compounded) | $199per four weeks, read from the seller's own semaglutide-against-tirzepatide comparison block on the tirzepatide product page | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See FancyMeds's current price →Good fit if
- Readers who need to see the billing interval stated rather than assumed.
- Buyers comparing a pay-as-you-go plan against a single payment for a fixed treatment length.
- People who want to know which dose arrives in which week before starting.
- Anyone who wants the operating company and its pharmacy named.
Look elsewhere if
- Readers who need one settled price; the hero and the payment block disagree.
- Buyers building an annual budget from a monthly figure — nothing here is monthly.
- Anyone who needs a named prescribing clinician or a service-area list.
- Readers for whom an FDA warning letter is disqualifying.
How this review was verified
- Re-read the priced product page and the HIPAA policy on 7 September 2026, comparing the requested path to the effective path on each and running a nonsense path against the host in the same run.
- Recorded the locale redirect explicitly rather than treating the bare domain as the address that answers.
- Stored every figure as non-monthly, because every figure on the page is stated per four weeks or per treatment.
- Read the hero, the payment block and the comparison block separately, which is how the two conflicting four-week figures were established rather than averaged.
- Screened the entity and the brand against FDA's live warning-letter datatable with a positive and a negative control in the same invocation, and re-fetched the letter to confirm its title matches the entity, reference number and date; a minted nonsense letter path returned a 404 in the same run.